These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29971461)

  • 1. Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships.
    Benturquia N; Chevillard L; Poiré C; Roussel O; Cohier C; Declèves X; Laplanche JL; Etheve-Quelquejeu M; Chen H; Mégarbane B
    Psychopharmacology (Berl); 2019 Mar; 236(3):891-901. PubMed ID: 29971461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
    Berquist MD; Traxler HK; Mahler AM; Baker LE
    Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.
    Nguyen JD; Aarde SM; Cole M; Vandewater SA; Grant Y; Taffe MA
    Neuropsychopharmacology; 2016 Oct; 41(11):2759-71. PubMed ID: 27277119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.
    Gannon BM; Galindo KI; Mesmin MP; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Mar; 43(4):761-769. PubMed ID: 28677665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
    Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
    Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications.
    White CM
    J Clin Pharmacol; 2016 Nov; 56(11):1319-1325. PubMed ID: 27029951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.
    Gannon BM; Mesmin MP; Sulima A; Rice KC; Collins GT
    Psychopharmacology (Berl); 2019 Mar; 236(3):1031-1041. PubMed ID: 30267131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.
    Aarde SM; Huang PK; Creehan KM; Dickerson TJ; Taffe MA
    Neuropharmacology; 2013 Aug; 71():130-40. PubMed ID: 23597511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.
    Huang PK; Aarde SM; Angrish D; Houseknecht KL; Dickerson TJ; Taffe MA
    Drug Alcohol Depend; 2012 Nov; 126(1-2):168-75. PubMed ID: 22664136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
    Risca HI; Zuarth-Gonzalez JD; Baker LE
    Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF
    Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
    Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.
    Collins GT; Sulima A; Rice KC; France CP
    Psychopharmacology (Berl); 2019 Dec; 236(12):3677-3685. PubMed ID: 31346629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma Using High-Pressure Liquid Chromatography-Tandem Mass Spectrometry.
    Gearlds C; Bouldin JB; McKinney M; Schreiner S; Brown SD; Pond BB
    Eur J Drug Metab Pharmacokinet; 2021 Nov; 46(6):771-778. PubMed ID: 34427910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine.
    Harvey EL; Burroughs RL; Baker LE
    Behav Pharmacol; 2017 Oct; 28(7):586-589. PubMed ID: 28704276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.
    Anizan S; Concheiro M; Lehner KR; Bukhari MO; Suzuki M; Rice KC; Baumann MH; Huestis MA
    Addict Biol; 2016 Mar; 21(2):339-47. PubMed ID: 25475011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.
    Gannon BM; Russell LN; Modi MS; Rice KC; Fantegrossi WE
    Drug Alcohol Depend; 2017 Oct; 179():408-415. PubMed ID: 28866386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
    Kohler RJ; Perrine SA; Baker LE
    Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.